ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

ClinicalTrials.gov ID: NCT00951496

Public ClinicalTrials.gov record NCT00951496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

Study identification

NCT ID
NCT00951496
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
1,560 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2009
Primary completion
Jan 10, 2016
Completion
Jan 10, 2016
Last update posted
May 18, 2026

2009 – 2016

United States locations

U.S. sites
36
U.S. states
7
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36688
Providence Alaska Medical Center Anchorage Alaska 99508
Saint Joseph's Hospital and Medical Center Phoenix Arizona 85013
Mayo Clinic in Arizona Scottsdale Arizona 85259
University of Arizona Cancer Center-North Campus Tucson Arizona 85719
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
PCR Oncology Arroyo Grande California 93420
Alta Bates Summit Medical Center-Herrick Campus Berkeley California 94704
Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California 91505
Mills-Peninsula Medical Center Burlingame California 94010
John Muir Medical Center-Concord Campus Concord California 94520
City of Hope Comprehensive Cancer Center Duarte California 91010
Marin General Hospital Greenbrae California 94904
Long Beach Memorial Medical Center-Todd Cancer Institute Long Beach California 90806
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
UCLA / Jonsson Comprehensive Cancer Center Los Angeles California 90095
Palo Alto Medical Foundation-Gynecologic Oncology Mountain View California 94040
Sutter Cancer Research Consortium Novato California 94945
Saint Joseph Hospital - Orange Orange California 92868
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868
Stanford Cancer Institute Palo Alto Palo Alto California 94304
Sutter Roseville Medical Center Roseville California 95661
Sutter Medical Center Sacramento Sacramento California 95816
University of California Davis Comprehensive Cancer Center Sacramento California 95817
University of California San Diego San Diego California 92103
California Pacific Medical Center-Pacific Campus San Francisco California 94115
UCSF Medical Center-Mount Zion San Francisco California 94115
Sutter Solano Medical Center/Cancer Center Vallejo California 94589
John Muir Medical Center-Walnut Creek Walnut Creek California 94598
Colorado Gynecologic Oncology Group Aurora Colorado 80010
University of Colorado Hospital Aurora Colorado 80045
University of Colorado Denver Colorado 80217-3364
Rocky Mountain Gynecologic Oncology PC Englewood Colorado 80110
Danbury Hospital Danbury Connecticut 06810
Hartford Hospital Hartford Connecticut 06102

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00951496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00951496 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →